ID   ASM_HUMAN      STANDARD;      PRT;   629 AA.
AC   P17405; P17406; Q13811; Q16837; Q16841;
DT   01-AUG-1990 (Rel. 15, Created)
DT   16-OCT-2001 (Rel. 40, Last sequence update)
DT   15-MAR-2004 (Rel. 43, Last annotation update)
DE   Sphingomyelin phosphodiesterase precursor (EC 3.1.4.12) (Acid
DE   sphingomyelinase) (aSMase).
GN   SMPD1 OR ASM.
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   SEQUENCE FROM N.A., AND ALTERNATIVE SPLICING.
RX   MEDLINE=91217097; PubMed=1840600;
RA   Schuchman E.H., Suchi M., Takahashi T., Sandhoff K., Desnick R.J.;
RT   "Human acid sphingomyelinase. Isolation, nucleotide sequence and
RT   expression of the full-length and alternatively spliced cDNAs.";
RL   J. Biol. Chem. 266:8531-8539(1991).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE=93183402; PubMed=1292508;
RA   Newrzella D., Stoffel W.;
RT   "Molecular cloning of the acid sphingomyelinase of the mouse and the
RT   organization and complete nucleotide sequence of the gene.";
RL   Biol. Chem. Hoppe-Seyler 373:1233-1238(1992).
RN   [3]
RP   SEQUENCE FROM N.A.
RX   MEDLINE=92155708; PubMed=1740330;
RA   Schuchman E.H., Levran O., Pereira L.V., Desnick R.J.;
RT   "Structural organization and complete nucleotide sequence of the gene
RT   encoding human acid sphingomyelinase (SMPD1).";
RL   Genomics 12:197-205(1992).
RN   [4]
RP   SEQUENCE FROM N.A., AND VARIANT ARG-157.
RX   MEDLINE=94012573; PubMed=8407868;
RA   Ida H., Rennert O.M., Eto Y., Chan W.Y.;
RT   "Cloning of a human acid sphingomyelinase cDNA with a new mutation
RT   that renders the enzyme inactive.";
RL   J. Biochem. 114:15-20(1993).
RN   [5]
RP   SEQUENCE OF 128-629 FROM N.A., PARTIAL SEQUENCE, AND
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Fibroblast;
RX   MEDLINE=90060003; PubMed=2555181;
RA   Quintern L.E., Schuchman E.H., Levran O., Suchi M., Ferlinz K.,
RA   Reinke H., Sandhoff K., Desnick R.J.;
RT   "Isolation of cDNA clones encoding human acid sphingomyelinase:
RT   occurrence of alternatively processed transcripts.";
RL   EMBO J. 8:2469-2473(1989).
RN   [6]
RP   CARBOHYDRATE-LINKAGE SITES.
RX   MEDLINE=97182640; PubMed=9030779;
RA   Ferlinz K., Hurwitz R., Moczall H., Lansmann S., Schuchman E.H.,
RA   Sandhoff K.;
RT   "Functional characterization of the N-glycosylation sites of human
RT   acid sphingomyelinase by site-directed mutagenesis.";
RL   Eur. J. Biochem. 243:511-517(1997).
RN   [7]
RP   DISULFIDE BONDS.
RX   MEDLINE=22518502; PubMed=12631268;
RA   Lansmann S., Schuette C.G., Bartelsen O., Hoernschemeyer J., Linke T.,
RA   Weisgerber J., Sandhoff K.;
RT   "Human acid sphingomyelinase.";
RL   Eur. J. Biochem. 270:1076-1088(2003).
RN   [8]
RP   VARIANT NPA SER-577.
RX   MEDLINE=92028849; PubMed=1718266;
RA   Ferlinz K., Hurwitz R., Sandhoff K.;
RT   "Molecular basis of acid sphingomyelinase deficiency in a patient
RT   with Niemann-Pick disease type A.";
RL   Biochem. Biophys. Res. Commun. 179:1187-1191(1991).
RN   [9]
RP   VARIANT NPA LEU-496.
RX   MEDLINE=91219449; PubMed=2023926;
RA   Levran O., Desnick R.J., Schuchman E.H.;
RT   "Niemann-Pick disease: a frequent missense mutation in the acid
RT   sphingomyelinase gene of Ashkenazi Jewish type A and B patients.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3748-3752(1991).
RN   [10]
RP   VARIANT NPB ARG-608 DEL.
RX   MEDLINE=91358737; PubMed=1885770;
RA   Levran O., Desnick R.J., Schuchman E.H.;
RT   "Niemann-Pick type B disease. Identification of a single codon
RT   deletion in the acid sphingomyelinase gene and genotype/phenotype
RT   correlations in type A and B patients.";
RL   J. Clin. Invest. 88:806-810(1991).
RN   [11]
RP   VARIANT NPA PRO-302.
RX   MEDLINE=93004773; PubMed=1391960;
RA   Levran O., Desnick R.J., Schuchman E.H.;
RT   "Identification and expression of a common missense mutation (L302P)
RT   in the acid sphingomyelinase gene of Ashkenazi Jewish type A
RT   Niemann-Pick disease patients.";
RL   Blood 80:2081-2087(1992).
RN   [12]
RP   VARIANT NPB ARG-436.
RX   MEDLINE=93244834; PubMed=1301192;
RA   Takahashi T., Desnick R.J., Takada G., Schuchman E.H.;
RT   "Identification of a missense mutation (S436R) in the acid
RT   sphingomyelinase gene from a Japanese patient with type B
RT   Niemann-Pick disease.";
RL   Hum. Mutat. 1:70-71(1992).
RN   [13]
RP   VARIANT NPA ILE-382, AND VARIANTS NPB ARG-242 AND SER-383.
RX   MEDLINE=92316934; PubMed=1618760;
RA   Takahashi T., Suchi M., Desnick R.J., Takada G., Schuchman E.H.;
RT   "Identification and expression of five mutations in the human acid
RT   sphingomyelinase gene causing types A and B Niemann-Pick disease.
RT   Molecular evidence for genetic heterogeneity in the neuronopathic and
RT   non-neuronopathic forms.";
RL   J. Biol. Chem. 267:12552-12558(1992).
RN   [14]
RP   VARIANT NPB GLY-391.
RX   MEDLINE=94328611; PubMed=8051942;
RA   Sperl W., Bart G., Vanier M.T., Christomanou H., Baldissera I.,
RA   Steichensdorf E., Paschke E.;
RT   "A family with visceral course of Niemann-Pick disease, macular halo
RT   syndrome and low sphingomyelin degradation rate.";
RL   J. Inherit. Metab. Dis. 17:93-103(1994).
RN   [15]
RP   VARIANT NPA THR-389.
RX   MEDLINE=96287387; PubMed=8680412;
RA   Schuchman E.H.;
RT   "Two new mutations in the acid sphingomyelinase gene causing type A
RT   Niemann-pick disease: N389T and R441X.";
RL   Hum. Mutat. 6:352-354(1995).
RN   [16]
RP   VARIANT NPA CYS-446.
RX   MEDLINE=96274768; PubMed=8693491;
RA   Takahashi T., Suchi M., Sato W., Ten S.B., Sakuragawa N.,
RA   Desnick R.J., Schuchman E.H., Takada G.;
RT   "Identification and expression of a missense mutation (Y446C) in the
RT   acid sphingomyelinase gene from a Japanese patient with type A
RT   Niemann-Pick disease.";
RL   Tohoku J. Exp. Med. 177:117-123(1995).
RN   [17]
RP   VARIANT NPA GLN-246.
RX   MEDLINE=96263741; PubMed=8664904;
RA   Ida H., Rennert O.M., Maekawa K., Eto Y.;
RT   "Identification of three novel mutations in the acid
RT   sphingomyelinase gene of Japanese patients with Niemann-Pick disease
RT   type A and B.";
RL   Hum. Mutat. 7:65-67(1996).
RN   [18]
RP   VARIANT NPB TYR-421.
RX   MEDLINE=22340429; PubMed=12369017;
RA   Simonaro C.M., Desnick R.J., McGovern M.M., Wasserstein M.P.,
RA   Schuchman E.H.;
RT   "The demographics and distribution of type B Niemann-Pick disease:
RT   novel mutations lead to new genotype/phenotype correlations.";
RL   Am. J. Hum. Genet. 71:1413-1419(2002).
RN   [19]
RP   VARIANTS NPA ARG-248; TYR-319; SER-463; LEU-475 AND HIS-537, AND
RP   VARIANTS NPB SER-371 AND ARG-608 DEL.
RX   MEDLINE=22444008; PubMed=12556236;
RA   Sikora J., Pavlu-Pereira H., Elleder M., Roelofs H., Wevers R.A.;
RT   "Seven novel Acid sphingomyelinase gene mutations in Niemann-Pick type
RT   A and B patients.";
RL   Ann. Hum. Genet. 67:63-70(2003).
CC   -!- FUNCTION: Converts sphingomyelin to ceramide. aSM also has
CC       phospholipase C activities toward 1,2-diacylglycerolphosphocholine
CC       and 1,2-diacylglycerolphosphoglycerol.
CC   -!- CATALYTIC ACTIVITY: Sphingomyelin + H(2)O = N-acylsphingosine +
CC       choline phosphate.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Lysosomal.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=ASM-1;
CC         IsoId=P17405-1; Sequence=Displayed;
CC       Name=2; Synonyms=ASM-2;
CC         IsoId=P17405-2; Sequence=VSP_000331, VSP_000332;
CC       Name=3; Synonyms=ASM-3;
CC         IsoId=P17405-3; Sequence=VSP_000333;
CC   -!- DISEASE: Defects in SMPD1 are the cause of Niemann-Pick disease
CC       type A (NPA) [MIM:257200]; also referred to as the classical
CC       infantile form. Niemann-Pick disease is a clinically and
CC       genetically heterogeneous recessive disorder. It is caused by the
CC       accumulation of sphingomyelin and other metabolically related
CC       lipids in the lysosomes, resulting in neurodegeneration starting
CC       from early life. Patients may show xanthomas, pigmentation,
CC       hepatosplenomegaly, lymphadenopathy and mental retardation.
CC       Niemann-Pick disease occurs more frequently among individuals of
CC       Ashkenazi Jewish ancestry than in the general population. NPA is
CC       characterized by very early onset in infancy and a rapidly
CC       progressive course leading to death by three years.
CC   -!- DISEASE: Defects in SMPD1 are the cause of Niemann-Pick disease
CC       type B (NPB) [MIM:607616]; also referred to as the visceral form.
CC       NPB has little if any neurologic involvement and patients may
CC       survive into adulthood.
CC   -!- MISCELLANEOUS: There are two types of sphingomyelinases: ASM
CC       (acid), and NSM (neutral).
CC   -!- MISCELLANEOUS: Isoform 1 is the most abundant (90%), isoforms 2
CC       (10%) and 3 (<1%) are only found at lower levels. Only isoform 1
CC       is a catalytic active enzyme.
CC   -!- SIMILARITY: Belongs to the acid sphingomyelinase family.
CC   -!- SIMILARITY: Contains 1 saposin B-type domain.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M59916; AAA58377.1; -.
DR   EMBL; M59917; AAA58378.1; -.
DR   EMBL; X63600; CAA45145.1; -.
DR   EMBL; X52678; CAA36901.1; -.
DR   EMBL; X52679; CAA36902.1; -.
DR   EMBL; M81780; AAA75008.1; -.
DR   EMBL; M81780; AAA75009.1; -.
DR   EMBL; X59960; CAA42584.1; -.
DR   PIR; S06958; S06958.
DR   PIR; S27009; A39825.
DR   Genew; HGNC:11120; SMPD1.
DR   MIM; 607608; -.
DR   MIM; 257200; -.
DR   MIM; 607616; -.
DR   GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; TAS.
DR   GO; GO:0007399; P:neurogenesis; TAS.
DR   GO; GO:0007165; P:signal transduction; TAS.
DR   GO; GO:0006684; P:sphingomyelin metabolism; TAS.
DR   InterPro; IPR004843; M-ppestrase.
DR   InterPro; IPR008139; SaposinB.
DR   Pfam; PF00149; Metallophos; 1.
DR   SMART; SM00118; SAPB; 1.
KW   Hydrolase; Glycosidase; Lysosome; Glycoprotein; Alternative splicing;
KW   Signal; Disease mutation.
FT   SIGNAL        1     46
FT   CHAIN        47    629       Sphingomyelin phosphodiesterase.
FT   DOMAIN       85    169       Saposin-like type B.
FT   DISULFID    120    131
FT   DISULFID    221    226
FT   DISULFID    227    250
FT   DISULFID    385    431
FT   DISULFID    584    588
FT   DISULFID    594    607
FT   CARBOHYD     86     86       N-linked (GlcNAc...).
FT   CARBOHYD    175    175       N-linked (GlcNAc...).
FT   CARBOHYD    335    335       N-linked (GlcNAc...).
FT   CARBOHYD    395    395       N-linked (GlcNAc...).
FT   CARBOHYD    520    520       N-linked (GlcNAc...).
FT   VARSPLIC    363    374       IGGFYALSPYPG -> YLSSVETQEGKR (in isoform
FT                                2).
FT                                /FTId=VSP_000331.
FT   VARSPLIC    375    418       Missing (in isoform 2).
FT                                /FTId=VSP_000332.
FT   VARSPLIC    363    418       Missing (in isoform 3).
FT                                /FTId=VSP_000333.
FT   VARIANT     157    157       C -> R (Seems to be less active).
FT                                /FTId=VAR_011387.
FT   VARIANT     242    242       G -> R (in NPB).
FT                                /FTId=VAR_005058.
FT   VARIANT     246    246       E -> Q (in NPA; 30% residual
FT                                activity).
FT                                /FTId=VAR_005059.
FT   VARIANT     248    248       S -> R (in NPA).
FT                                /FTId=VAR_015287.
FT   VARIANT     302    302       L -> P (in NPA; in 23% of NPA Ashkenazi
FT                                Jewish patients).
FT                                /FTId=VAR_005060.
FT   VARIANT     319    319       H -> Y (in NPA).
FT                                /FTId=VAR_015288.
FT   VARIANT     371    371       P -> S (in NPB).
FT                                /FTId=VAR_015289.
FT   VARIANT     382    382       M -> I (in NPA).
FT                                /FTId=VAR_005061.
FT   VARIANT     383    383       N -> S (in NPB).
FT                                /FTId=VAR_005062.
FT   VARIANT     389    389       N -> T (in NPA).
FT                                /FTId=VAR_005063.
FT   VARIANT     391    391       W -> G (in NPB; low sphingomyelin
FT                                degradation rates).
FT                                /FTId=VAR_005064.
FT   VARIANT     421    421       H -> Y (in NPB).
FT                                /FTId=VAR_015290.
FT   VARIANT     436    436       S -> R (in NPB).
FT                                /FTId=VAR_005065.
FT   VARIANT     446    446       Y -> C (in NPA).
FT                                /FTId=VAR_011388.
FT   VARIANT     463    463       F -> S (in NPA).
FT                                /FTId=VAR_015291.
FT   VARIANT     475    475       P -> L (in NPA).
FT                                /FTId=VAR_015292.
FT   VARIANT     496    496       R -> L (in NPA; in 32% of NPA Ashkenazi
FT                                Jewish patients).
FT                                /FTId=VAR_005066.
FT   VARIANT     537    537       Y -> H (in NPA).
FT                                /FTId=VAR_015293.
FT   VARIANT     577    577       G -> S (in NPA).
FT                                /FTId=VAR_005067.
FT   VARIANT     608    608       Missing (in NPB; prevalent among NPB
FT                                patients from the North-African Maghreb
FT                                region).
FT                                /FTId=VAR_005068.
FT   CONFLICT     35     36       Missing (in Ref. 4).
FT   CONFLICT     36     36       V -> A (in Ref. 3).
FT   CONFLICT    322    322       T -> I (in Ref. 1).
FT   CONFLICT    506    506       R -> G (in Ref. 3 and 4).
SQ   SEQUENCE   629 AA;  69851 MW;  C994FCB1458942AC CRC64;
     MPRYGASLRQ SCPRSGREQG QDGTAGAPGL LWMGLVLALA LALALALSDS RVLWAPAEAH
     PLSPQGHPAR LHRIVPRLRD VFGWGNLTCP ICKGLFTAIN LGLKKEPNVA RVGSVAIKLC
     NLLKIAPPAV CQSIVHLFED DMVEVWRRSV LSPSEACGLL LGSTCGHWDI FSSWNISLPT
     VPKPPPKPPS PPAPGAPVSR ILFLTDLHWD HDYLEGTDPD CADPLCCRRG SGLPPASRPG
     AGYWGEYSKC DLPLRTLESL LSGLGPAGPF DMVYWTGDIP AHDVWHQTRQ DQLRALTTVT
     ALVRKFLGPV PVYPAVGNHE STPVNSFPPP FIEGNHSSRW LYEAMAKAWE PWLPAEALRT
     LRIGGFYALS PYPGLRLISL NMNFCSRENF WLLINSTDPA GQLQWLVGEL QAAEDRGDKV
     HIIGHIPPGH CLKSWSWNYY RIVARYENTL AAQFFGHTHV DEFEVFYDEE TLSRPLAVAF
     LAPSATTYIG LNPGYRVYQI DGNYSRSSHV VLDHETYILN LTQANIPGAI PHWQLLYRAR
     ETYGLPNTLP TAWHNLVYRM RGDMQLFQTF WFLYHKGHPP SEPCGTPCRL ATLCAQLSAR
     ADSPALCRHL MPDGSLPEAQ SLWPRPLFC
//
